BEACON INVESTMENT ADVISORY SERVICES, INC. – Alnylam Pharmaceuticals, Inc. Transaction History
BEACON INVESTMENT ADVISORY SERVICES, INC. portfolio value:
$2.13M
portfolio value
BEACON INVESTMENT ADVISORY SERVICES, INC. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -2.08% | -227 shares | 547K | $200.16 | 10.67K |
Q2 2022 | share | Decrease | -0.78% | -86 shares | -204K | $145.85 | 10.90K |
Q1 2022 | share | Decrease | -0.19% | -21 shares | -73K | $163.29 | 10.99K |
Q4 2021 | share | Increase | +18.66% | 1.73K shares | 116K | $171.03 | 11.01K |
Q3 2021 | share | Increase | +3.87% | 346 shares | 237K | $188.81 | 9.28K |
Q2 2021 | share | Increase | +7.22% | 602 shares | 338K | $169.52 | 8.93K |
Q1 2021 | share | Increase | +83.95% | 3.80K shares | 588K | $141.19 | 8.33K |
Q4 2020 | share | Increase | 0.00% | 4.53K shares | 589K | $129.97 | 4.53K |